HK1057558A1 - Non-nucleoside reverse transcriptase inhibitors. - Google Patents

Non-nucleoside reverse transcriptase inhibitors.

Info

Publication number: HK1057558A1
Authority: HK; Hong Kong
Prior art keywords: reverse transcriptase; transcriptase inhibitors; nucleoside reverse; group; inhibitors
Prior art date: 2000-06-16

Application number

HK04100468A

Other languages

English (en)

Inventor

Bruno Simoneau

Original Assignee

Bohringer Ingelheim Canada Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-16

Filing date

2004-01-21

Publication date

2004-04-08

2004-01-21 Application filed by Bohringer Ingelheim Canada Ltd filed Critical Bohringer Ingelheim Canada Ltd

2004-04-08 Publication of HK1057558A1 publication Critical patent/HK1057558A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
AIDS & HIV (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Saccharide Compounds (AREA)
Steroid Compounds (AREA)

HK04100468A 2000-06-16 2004-01-21 Non-nucleoside reverse transcriptase inhibitors. HK1057558A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US21232900P	2000-06-16	2000-06-16
US25663800P	2000-12-18	2000-12-18
PCT/CA2001/000890 WO2001096338A1 (en)	2000-06-16	2001-06-14	Non-nucleoside reverse transcriptase inhibitors

Publications (1)

Publication Number	Publication Date
HK1057558A1 true HK1057558A1 (en)	2004-04-08

Family

ID=26907019

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK04100468A HK1057558A1 (en)	2000-06-16	2004-01-21	Non-nucleoside reverse transcriptase inhibitors.

Country Status (36)

Country	Link
US (1)	US6420359B1 (de)
EP (1)	EP1294720B1 (de)
JP (1)	JP3923894B2 (de)
KR (1)	KR20030017540A (de)
CN (1)	CN1178939C (de)
AR (1)	AR028958A1 (de)
AT (1)	ATE322492T1 (de)
AU (2)	AU7037001A (de)
BG (1)	BG107348A (de)
BR (1)	BR0102377A (de)
CA (1)	CA2411766C (de)
CZ (1)	CZ20024114A3 (de)
DE (1)	DE60118560T2 (de)
DK (1)	DK1294720T3 (de)
EA (1)	EA005598B1 (de)
EE (1)	EE200200690A (de)
ES (1)	ES2261433T3 (de)
HK (1)	HK1057558A1 (de)
HR (1)	HRP20021003A2 (de)
HU (1)	HUP0301105A2 (de)
IL (1)	IL152819A0 (de)
MX (1)	MXPA02012205A (de)
MY (1)	MY130375A (de)
NO (1)	NO323830B1 (de)
NZ (1)	NZ523549A (de)
PE (1)	PE20020083A1 (de)
PL (1)	PL360370A1 (de)
PT (1)	PT1294720E (de)
SA (1)	SA01220202B1 (de)
SK (1)	SK17722002A3 (de)
TW (1)	TWI270547B (de)
UA (1)	UA74834C2 (de)
UY (1)	UY26767A1 (de)
WO (1)	WO2001096338A1 (de)
YU (1)	YU94202A (de)
ZA (1)	ZA200209807B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6716836B2 (en)	2001-03-22	2004-04-06	Boehringer Ingelheim (Canada) Ltd.	Non-nucleoside reverse transcriptase inhibitors
US6673791B2 (en)	2001-07-30	2004-01-06	Boehringer Ingelheim (Canada) Ltd.	Non-nucleoside reverse transcriptase inhibitors
US6706706B2 (en)	2002-03-27	2004-03-16	Boehringer Ingelheim International Gmbh	Non-nucleoside reverse transcriptase inhibitors
US6806265B2 (en) *	2002-05-16	2004-10-19	Boehringer Ingelheim International Gmbh	Non-nucleoside reverse transcriptase inhibitors
US6759533B2 (en) *	2002-06-28	2004-07-06	Boehringer Ingelheim Pharmaceuticals, Inc.	Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors
US7642277B2 (en)	2002-12-04	2010-01-05	Boehringer Ingelheim International Gmbh	Non-nucleoside reverse transcriptase inhibitors
PL376900A1 (pl) *	2002-12-16	2006-01-09	Boehringer Ingelheim International Gmbh	Zastosowanie kombinacji zawierającej nienukleozydowy inhibitor odwrotnej transkryptazy (NNRTI) i inhibitor cytochromu P450, taki jak inhibitor proteazy
EP1610782A1 (de) *	2003-03-27	2006-01-04	Boehringer Ingelheim International GmbH	Antivirale kombination eines dipyridodiazepinons und einer weiteren antiretroviralen verbindung
US7309700B2 (en) *	2004-04-02	2007-12-18	Boehringer Ingelheim International Gmbh	Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2′,3′-e] [1,4]diazepin-6-one
US20060025480A1 (en)	2004-08-02	2006-02-02	Boehringer Ingelheim International Gmbh	Benzoic acid derivatives as non nucleoside reverse transcriptase inhibitors
US7151174B2 (en) *	2004-11-05	2006-12-19	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Process for making a non-nucleoside HIV-1 reverse transcriptase inhibitor
US7282583B2 (en) *	2005-12-05	2007-10-16	Boehringer Ingelheim International Gmbh	Process for making 5,11-Dihydro-11-ethyl-5-methyl-8{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-di pyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one
EP2085390A1 (de)	2008-01-31	2009-08-05	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Markierte Analoge von Halobenzamiden als multimodale Radiopharmazeutika und ihre Vorläufer
JP5643290B2 (ja) *	2009-04-09	2014-12-17	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｈｉｖ複製の阻害薬

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5366972A (en) *	1989-04-20	1994-11-22	Boehringer Ingelheim Pharmaceuticals, Inc.	5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
US5705499A (en) *	1995-10-06	1998-01-06	Boehringer Ingelheim Pharmaceuticals, Inc.	8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection

2001
- 2001-05-30 TW TW090113049A patent/TWI270547B/zh not_active IP Right Cessation
- 2001-06-12 US US09/879,447 patent/US6420359B1/en not_active Expired - Lifetime
- 2001-06-12 BR BR0102377-2A patent/BR0102377A/pt not_active IP Right Cessation
- 2001-06-13 UY UY26767A patent/UY26767A1/es not_active Application Discontinuation
- 2001-06-14 EP EP01949124A patent/EP1294720B1/de not_active Expired - Lifetime
- 2001-06-14 AT AT01949124T patent/ATE322492T1/de active
- 2001-06-14 SK SK1772-2002A patent/SK17722002A3/sk not_active Application Discontinuation
- 2001-06-14 CA CA002411766A patent/CA2411766C/en not_active Expired - Fee Related
- 2001-06-14 HU HU0301105A patent/HUP0301105A2/hu unknown
- 2001-06-14 ES ES01949124T patent/ES2261433T3/es not_active Expired - Lifetime
- 2001-06-14 EA EA200201255A patent/EA005598B1/ru not_active IP Right Cessation
- 2001-06-14 DE DE60118560T patent/DE60118560T2/de not_active Expired - Lifetime
- 2001-06-14 UA UA2003010387A patent/UA74834C2/uk unknown
- 2001-06-14 AU AU7037001A patent/AU7037001A/xx active Pending
- 2001-06-14 DK DK01949124T patent/DK1294720T3/da active
- 2001-06-14 MX MXPA02012205A patent/MXPA02012205A/es active IP Right Grant
- 2001-06-14 EE EEP200200690A patent/EE200200690A/xx unknown
- 2001-06-14 PE PE2001000560A patent/PE20020083A1/es not_active Application Discontinuation
- 2001-06-14 KR KR1020027017173A patent/KR20030017540A/ko active IP Right Grant
- 2001-06-14 YU YU94202A patent/YU94202A/sh unknown
- 2001-06-14 JP JP2002510480A patent/JP3923894B2/ja not_active Expired - Lifetime
- 2001-06-14 PL PL36037001A patent/PL360370A1/xx not_active Application Discontinuation
- 2001-06-14 CZ CZ20024114A patent/CZ20024114A3/cs unknown
- 2001-06-14 NZ NZ523549A patent/NZ523549A/en unknown
- 2001-06-14 IL IL15281901A patent/IL152819A0/xx unknown
- 2001-06-14 PT PT01949124T patent/PT1294720E/pt unknown
- 2001-06-14 AU AU2001270370A patent/AU2001270370B2/en not_active Ceased
- 2001-06-14 WO PCT/CA2001/000890 patent/WO2001096338A1/en active IP Right Grant
- 2001-06-14 CN CNB018112692A patent/CN1178939C/zh not_active Expired - Fee Related
- 2001-06-15 AR ARP010102870A patent/AR028958A1/es unknown
- 2001-06-15 MY MYPI20012820A patent/MY130375A/en unknown
- 2001-07-07 SA SA01220202A patent/SA01220202B1/ar unknown
2002
- 2002-12-03 BG BG107348A patent/BG107348A/bg unknown
- 2002-12-03 ZA ZA200209807A patent/ZA200209807B/en unknown
- 2002-12-05 NO NO20025844A patent/NO323830B1/no unknown
- 2002-12-13 HR HR20021003A patent/HRP20021003A2/hr not_active Application Discontinuation
2004
- 2004-01-21 HK HK04100468A patent/HK1057558A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
PL360370A1 (en)	2004-09-06
EA200201255A1 (ru)	2003-06-26
CZ20024114A3 (cs)	2003-04-16
UA74834C2 (en)	2006-02-15
EE200200690A (et)	2004-06-15
ES2261433T3 (es)	2006-11-16
MY130375A (en)	2007-06-29
CN1178939C (zh)	2004-12-08
PT1294720E (pt)	2006-06-30
AR028958A1 (es)	2003-05-28
WO2001096338A1 (en)	2001-12-20
AU2001270370B2 (en)	2006-08-03
EA005598B1 (ru)	2005-04-28
IL152819A0 (en)	2003-06-24
NO20025844D0 (no)	2002-12-05
YU94202A (sh)	2005-11-28
SK17722002A3 (sk)	2003-06-03
NO20025844L (no)	2002-12-05
EP1294720A1 (de)	2003-03-26
HUP0301105A2 (hu)	2003-08-28
HRP20021003A2 (en)	2005-02-28
KR20030017540A (ko)	2003-03-03
DE60118560T2 (de)	2006-09-28
JP2004502787A (ja)	2004-01-29
DK1294720T3 (da)	2006-07-31
PE20020083A1 (es)	2002-02-28
ZA200209807B (en)	2003-10-16
MXPA02012205A (es)	2003-09-10
UY26767A1 (es)	2002-01-31
TWI270547B (en)	2007-01-11
CN1436189A (zh)	2003-08-13
CA2411766C (en)	2006-05-23
US20020028807A1 (en)	2002-03-07
NO323830B1 (no)	2007-07-09
SA01220202B1 (ar)	2006-09-05
US6420359B1 (en)	2002-07-16
AU7037001A (en)	2001-12-24
ATE322492T1 (de)	2006-04-15
JP3923894B2 (ja)	2007-06-06
BR0102377A (pt)	2002-02-19
BG107348A (bg)	2004-06-30
EP1294720B1 (de)	2006-04-05
CA2411766A1 (en)	2001-12-20
DE60118560D1 (de)	2006-05-18
NZ523549A (en)	2004-08-27

Publication	Publication Date	Title
HK1057558A1 (en)	2004-04-08	Non-nucleoside reverse transcriptase inhibitors.
PT1585739E (pt)	2011-05-13	Arilciclopropilacetamidas substitu?das como activadores da glucocinase
AR077416A2 (es)	2011-08-24	Compuesto polimorfo estable de flibanserina , procedimiento industrial para su preparacion y uso del mismo para preparar medicamentos
NO20045152L (no)	2005-01-24	Ikke-nukleosid-reverstranskriptaseinhibitorer
EP1354880A4 (de)	2004-08-25	Halogenverbindungen, die als agonisten am thrombopoietinrezeptor wirken
JO2035B1 (en)	1999-05-15	Pyrazine compounds
MX338829B (es)	2016-05-03	Metodo para preparar 3-halo-4,5-dihidro-1h-pirazoles.
WO2008005519A3 (en)	2008-04-24	Novel pyridazine compound and use thereof
HUP0300480A2 (hu)	2003-06-28	2-Acil-indol-származékok és tumorellenes szerként történő alkalmazásuk
CA2495721A1 (en)	2004-10-07	Non-nucleoside reverse transcriptase inhibitors
AR054386A1 (es)	2007-06-20	Moduladores de quinasas con estructuras de alquiloquinolina y alquilquinazolina
MX2021011286A (es)	2022-01-24	Compuestos de heterociclil(fenil)metanol útiles en el tratamiento de la hiperglucemia.
WO2002024663A3 (en)	2003-10-09	Pyrimidine compounds and their use
WO2003035620A1 (fr)	2003-05-01	Compose bicyclique
RS50229B (sr)	2009-07-15	Analozi vitamina d3
AU572660B2 (en)	1988-05-12	Bis (4-aminophenyl) sulfones
TW200616933A (en)	2006-06-01	Benzoic acid derivatives as non-nucleoside reverse transcriptase inhibitors
YU6396A (sh)	1999-06-15	Kombinacija inhibitora hiv proteaze sa drugim jedinjenjima za terapiju hiv infekcija
IL145449A0 (en)	2002-06-30	Processes for preparing pesticidal intermediates
MXPA03007966A (es)	2004-05-24	Inhibidores de transcriptasa reversa sin nucleosido.
TR200100070A2 (tr)	2001-08-21	Bileşim
TW198680B (de)	1993-01-21
WO2021130700A8 (en)	2021-12-30	Compound for the treatment of the hemolytic-uremic syndrome
IS7378A (is)	2004-07-29	Lyfjasamsetningar sem samanstanda af 2-(4-etoxý-fenýl)-3-(4-metansúl-fónýl-fenýl)-pýrasóló 1,5-bípýridasín á nanóagna formi
UA96296C2 (en)	2011-10-25	Pyridazine compounds and use thereof

Legal Events

Date	Code	Title	Description
2009-01-23	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20080614